TACIZOL

This brand name is authorized in Nigeria.

Active ingredients

The drug TACIZOL contains one active pharmaceutical ingredient (API):

1	Albendazole UNII F4216019LN - ALBENDAZOLE
	Albendazole causes degenerative alterations in the tegument and intestinal cells of the worm by binding to the colchicine-sensitive site of tubulin, thus inhibiting its polymerization or assembly into microtubules.
	Read more about Albendazole

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
B4-7344	Suspension	TACIZOL SUSPENSION SUSP 100 mg/5 mL	TACIZOL SUSPENSION B4-7344 TACIZOL SUSPENSION Albendazole usp 100mg, Sodium Methyl Paraben, Sodium Propyl paraben, Sodium benzoate, Sucrose, Sorbitol, Glycerin, Propylene glycol, Poly sorbate-80, citric acid monohydrate, sodium citrate, Xanthan gum, Sodium CMC, Colloidal silicon dioxide, (aerosil), Colour erythrosine supra, Flavour peppermint, Flavour rose white liquid, Sodium Sachharin Suspension Prescription Only Medicine (POM) GBGL PHARMA LIMITED, OGUNTONA CRESCENT GBAGADA PHASE 1 LAGOS LAGOS Nigeria Ratnamani Healthcare Pvt. Ltd., SURVEY NO. 750/1, AHMEDABAD-MEHSANA HIGHWAY, VII: INDRAD 382721, INDIA, India 26/01/2023 25/01/2028	26/01/2023
B4-7552	Tablet	TACIZOL TABLET TAB 400 mg	TACIZOL TABLET B4-7552 TACIZOL TABLET c USP 400MG, Lactose, Micro crystalline cellulose, Mannitol, Sodium CMC, Sodium benzoate, Citric acid anhydrous, Color sunset yellow supra, Sodium starch glycolate, Talcum, Magnesium stearate, Colloidal silicon dioxide, Aspartame, Sodium chloride, Flavour Orange Powder EC Prescription Only Medicine (POM) GBGL PHARMA LIMITED, OGUNTONA CRESCENT GBAGADA PHASE 1 LAGOS LAGOS RATNAMANI HEALTHCARE PVT. LIMITED, NO. 750/1 VILLAGE: INDRAD, TAL:KADI, DIST: MESHANA, GUJARAT, INDIA, India 2/23/2023 2/22/2028	23/02/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
P02CA03	Albendazole	P Antiparasitic products, insecticides and repellents → P02 Anthelmintics → P02C Antinematodal agents → P02CA Benzimidazole derivatives
Discover more medicines within P02CA03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	B4-7344, B4-7552